Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines forCYP3A5Genotype and Tacrolimus Dosing-Reference-Cited by-同舟云学术

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines forCYP3A5Genotype and Tacrolimus Dosing

Published:2015-06-03 Issue:1 Volume:98 Page:19-24
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Birdwell KA¹²,Decker B³,Barbarino JM⁴,Peterson JF²⁵,Stein CM²⁶,Sadee W⁷,Wang D⁷,Vinks AA⁸⁹,He Y¹⁰,Swen JJ¹¹,Leeder JS¹²,van Schaik RHN¹³,Thummel KE¹⁴,Klein TE⁴,Caudle KE¹⁵,MacPhee IAM¹⁶

Affiliation:

1. Division of Nephrology Department of Medicine; Vanderbilt University; Nashville Tennessee USA

2. Department of Medicine; Vanderbilt University; Nashville Tennessee USA

3. Division of Nephrology and Division of Clinical Pharmacology; Indiana University School of Medicine; Indianapolis Indiana USA

4. Department of Genetics; Stanford University; Stanford California USA

5. Department of Biomedical Informatics; Vanderbilt University; Nashville Tennessee USA

6. Department of Pharmacology; Vanderbilt University; Nashville Tennessee USA

7. Center for Pharmacogenomics; School of Medicine, The Ohio State University; Columbus Ohio USA

8. Division of Clinical Pharmacology; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio USA

9. Department of Pediatrics; College of Medicine, University of Cincinnati; Cincinnati Ohio USA

10. Institute of Clinical Pharmacology, Central South University; Changsha Hunan Peoples Republic of China

11. Department of Clinical Pharmacy and Toxicology; Leiden University Medical Center; Leiden The Netherlands

12. Division of Clinical Pharmacology and Therapeutic Innovation, Department of Pediatrics; Children's Mercy Hospitals and Clinics; Kansas City Missouri USA

13. Department of Clinical Chemistry; Erasmus MC Rotterdam; The Netherlands

14. Department of Pharmaceutics; University of Washington; Seattle Washington USA

15. Department of Pharmaceutical Sciences; St. Jude Children's Research Hospital; Memphis Tennessee USA

16. Institute of Medical and Biomedical Education, Renal Medicine, St. George's, University of London; London UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference40 articles.

1. The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons;Finta;Gene,2000

2. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression;Kuehl;Nat. Genet.,2001

3. CYP3A5 variant allele frequencies in Dutch caucasians;Schaik;Clin. Chem.,2002

4. CYP3A variation and the evolution of salt-sensitivity variants;Thompson;Am. J. Hum. Genet.,2004

5. The role of tacrolimus in renal transplantation;Bowman;Expert Opin. Pharmacother.,2008

Cited by 526 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically-based pharmacokinetic modelling to investigate the effect of CYP3A4/3A5 maturation on tacrolimus pharmacokinetics in paediatric HSCT patients;European Journal of Pharmaceutical Sciences;2024-10

2. Hemoglobin and total bilirubin may affect tacrolimus clearance in liver transplant patient following the early postoperative period: a case report;Journal of Medical Case Reports;2024-09-05

3. Posttransplant complications: molecular mechanisms and therapeutic interventions;MedComm;2024-09

4. Effect of CYP3A5 Gene Polymorphisms on Tacrolimus Blood Concentrations and Adverse Events in Allogeneic Hematopoietic Stem Cell Transplant Patients;Transplantation Proceedings;2024-09

5. mTOR gene variant rs2295080 might be a risk factor for atherosclerosis in Iranian women with type 2 diabetes mellitus;BMC Endocrine Disorders;2024-08-29